NDC 71929-070 Recelltis Wound Cream
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 71929 - Cellnovation Technology
- 71929-070 - Recelltis
Product Packages
NDC Code 71929-070-28
Package Description: 28 g in 1 TUBE
Product Details
What is NDC 71929-070?
What are the uses for Recelltis Wound Cream?
Which are Recelltis Wound Cream UNII Codes?
The UNII codes for the active ingredients in this product are:
- LIDOCAINE (UNII: 98PI200987)
- LIDOCAINE (UNII: 98PI200987) (Active Moiety)
- POLYMYXIN B SULFATE (UNII: 19371312D4)
- POLYMYXIN B (UNII: J2VZ07J96K) (Active Moiety)
- BACITRACIN ZINC (UNII: 89Y4M234ES)
- BACITRACIN (UNII: 58H6RWO52I) (Active Moiety)
- NEOMYCIN SULFATE (UNII: 057Y626693)
- NEOMYCIN (UNII: I16QD7X297) (Active Moiety)
Which are Recelltis Wound Cream Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILVER (UNII: 3M4G523W1G)
What is the NDC to RxNorm Crosswalk for Recelltis Wound Cream?
- RxCUI: 2001994 - bacitracin zinc 400 UNT / lidocaine HCl 20 MG / neomycin 3.5 MG / polymyxin B 5,000 UNT per GM Topical Cream
- RxCUI: 2001994 - bacitracin zinc 0.4 UNT/ML / lidocaine hydrochloride 0.02 MG/ML / neomycin 0.0035 MG/ML / polymyxin B 5 UNT/ML Topical Cream
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".